Bausch & Lomb Recalls ReNu Multi-Purpose Solution Overseas

Contact lens maker <"http://www.yourlawyer.com/topics/overview/renu_contact_solution">Bausch & Lomb has issued a recall for ReNu Multi-Purpose Solution. The contact lens solution recall is being in issued in Europe, Guadeloupe, Martinique and Reunion, and does not affect products sold in the US.

According to a statement issued by Bausch & Lomb, the recall involves three lots of ReNu Multi-Purpose Solution: C9116, C9009 and C9048. The Bausch & Lomb statement said testing found that the recalled contact lens solution may not meet all of the specification criteria at its end-of-shelf life date, which for batches C9116 and C9009 is March 2011 and for C9048 is April 2011.

The Bausch & Lomb statement read: “We decided to initiate the quality-related recall after our Stability Monitoring Program showed that the performance trend of certain lots did not meet our expectations.”

Bausch & Lomb said it has contacted all eye care professionals and retailers directly who were shipped the affected products advising them of the steps they need to take to return the merchandise.

No other Bausch & Lomb products are included in this recall.

This is not the first time that Bausch & Lomb has conducted a recall of a ReNu product. Bausch & Lomb pulled ReNu with MoistureLoc from Asian markets in February 2006, and did the same in the US in April of that year, after it was linked to an outbreak of Fusarium keratitis, a potentially blinding eye infection. The company would ultimately issue a worldwide recall of ReNu with MoistureLoc on May 15, 2006.

A US Centers for Disease Control (CDC) report on the outbreak found that those infected with Fusarium keratitis were 20 time more likely to have used the ReNu with MoistureLoc solution. The CDC report determined that bad hygiene habits among users were not to blame for the infections, but that the contact lens solution appeared to have poor disinfectant qualities. The CDC ultimately confirmed 180 cases of Fusarium keratitis in the US. According to the Associated Press, at least 60 more Americans needed vision-saving corneal transplants.

The ReNu with MoistureLoc debacle spawned nearly 2,000 personal injury lawsuits.

This entry was posted in Pharmaceuticals. Bookmark the permalink.


© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.